Molecular Carcinogenesis / Chemoprevention Clinical Trials


Protocol No.PITitle
OSU-10037Brian FochtHabitual Physical activity Patterns, Muscle Mass, and Physical Function in Men Undergoing Androgen Deprivation Therapy (ADT)
OSU-12008Brian FochtThe Intensive Diet and Exercise Adherence Trial-Pilot (IDEA-P): A Feasibility Study of a Lifestyle Intervention in Men Undergoing Androgen Deprivation Therapy
OSU-09052Susan MalleryEvaluation of Oral Rinse Formulations for Sustained Salivary levels of Black Raspberry Anthocyanins
CALGB-90601Amir MortazaviA Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin, and Placebo In Patients With Advanced Transitional Cell Carcinoma
CALGB-150609Amir MortazaviEmbedded Companion to CALGB-90601
CALGB-60707Amir MortazaviEmbedded Companion to CALGB-90601
OSU-13189Greg OttersonAn Open-label, Randomized Phase IIB/III Active Control Study of Second-line HyperAcute®-Lung (tergenpumatucel-L) Immunotherapy versus Docetaxel in Progressive or Relapsed Non-Small Cell Lung Cancer
CALGB-70809Greg OttersonEmbedded Companion to CALGB-30506: Quality of Life in Patients on CALGB-30506
OSU-08070Traci WilgusVascular Endothelial Growth Facto Signaling in Skin Carcinogenesis
OSU-9990Lisa YeeFatty Acids & Peroxisome Proliferator-Activated Receptors in Breast Cancer Prevention
OSU-0253Lisa YeeBreast Fine Needle Aspiration and Breast Duct Fluid Collection in High Risk Breast Patients.
OSU-13034Lisa YeeNanoemulsion curcumin for obesity, inflammation and breast cancer prevention a pilot trial
OSU-13130Lisa YeeOmega-3 fatty acids and ERPR(-) and HER-2/neu(+) breast cancer prevention

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 300 W. 10th Ave. Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu